164149-27-3

Basic information

• Product Name: 1-Boc-4-(3-broMopropyl)piperidine
• Synonyms: 1-tert-Butoxycarbonyl-4-(3-bromopropyl)piperidine;4-(3-Bromopropyl)-1-(tert-butoxycarbonyl)piperidine;4-(3-Bromopropyl)piperidine-1-carboxylic acid tert-butyl ester;N-Boc-4-(3-bromopropyl)piperidine;4-(3-Bromopropyl)-1-Boc-piperidine;3-(4-(N-Boc-piperidyl))-1-bromopropane;1-Boc-4-(3-broMopropyl)piperidine;tert-Butyl 4-(3-bromopropyl)-piperidine-1-carboxylate
• CAS NO: 164149-27-3
• Molecular Formula: C₁₃H₂₄BrNO₂
• Molecular Weight: 306.23916
• Product Categories: CMLLYL
• Mol File: 164149-27-3.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 349.8±15.0 °C(Predicted)
• Appearance: /
• Density: 1 +-.0.06 g/cm3(Predicted)
• PKA: -1.37±0.40(Predicted)
• CAS DataBase Reference: 1-Boc-4-(3-broMopropyl)piperidine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Boc-4-(3-broMopropyl)piperidine(164149-27-3)
• EPA Substance Registry System: 1-Boc-4-(3-broMopropyl)piperidine(164149-27-3)

Safety Data

• Hazardous Substances Data: 164149-27-3(Hazardous Substances Data)

Usage

General Description

1-Boc-4-(3-bromopropyl)piperidine, also known as 4-(3-Bromopropyl)-1-piperidinecarboxylic acid tert-butyl ester, is a chemical compound with the molecular formula C14H25BrNO2. It is a piperidine derivative with a tert-butyloxycarbonyl (Boc) protecting group on the nitrogen atom and a bromopropyl substituent on the piperidine ring. 1-Boc-4-(3-broMopropyl)piperidine is commonly used as a building block in organic synthesis and medicinal chemistry, particularly in the development of pharmaceutical drugs. Its unique structure and properties make it an important reagent for the synthesis of various bioactive molecules. Additionally, it is a valuable intermediate in the production of diverse compounds with potential pharmacological activities.

Upstream product

• 2629-72-3 4-(3-Hydroxypropyl)pyridine 
• 7037-49-2 3-(piperidin-4-yl)propan-1-ol 
• 156185-63-6 N-Boc-piperidin-4-yl-propanol 

Downstream Products

• 193630-36-3 1-{3-[N-(tert-butyloxycarbonyl)-3-piperidinyl]propyl}-2-[(4-chlorophenoxy)methyl]-4-({3-[N-(tert-butyloxycarbonyl)-4-piperidinyl]propyl}oxy)benzimidazole 
• 267242-28-4 4-{3-[benzyloxycarbonyl-(6-ethoxycarbonylmethyl-5-oxo-5,6,7,8-tetrahydro-naphthalen-2-yl)-amino]-propyl}-piperidine-1-carboxylic acid tert-butyl ester 
• 873546-81-7 tert-butyl 4-[3-(4-cyano-3-fluorophenoxy)propyl]-1-piperidinecarboxylate 
• 912362-37-9 C₂₉H₃₉F₂N₃O₄ 
• 873546-85-1 4-(3-{1-[3-(4-cyano-3-fluorophenoxy) propyl]-4-piperidinyl}propoxy)-2-fluorobenzonitrile 
• 873546-83-9 4-(3-{1-[3-(4-cyanophenoxy)propyl]-4-piperidinyl}propoxy)-2-fluorobenzonitrile 
• 873546-80-6 4-(3-{4-[3-(4-cyanophenoxy)propyl]-1-piperidinyl}propoxy)benzonitrile 
• 873546-82-8 2-fluoro-4-[3-(4-piperidinyl)propoxy] benzonitrile 
• 873546-79-3 4-[3-(4-piperidinyl)propoxy]benzonitrile 
• 873546-31-7 4-{3-[1-(3-{4-[amino(imino)methyl]phenoxy}propyl)piperidin-4-yl]propoxy}benzamidine 
• 1433607-15-8 (E)-N-Boc-4-(((2-(2-amino-7-(4-fluoro-2-(pyridin-3-yl)phenyl)-4-methyl-7,8-dihydro-6H-quinazolin-5-ylidene)amino)oxy)propyl)piperidine 
• 1433607-08-9 (E)-2-amino-7-(4-fluoro-2-(pyridin-3-yl)phenyl)-4-methyl-7,8-dihydro-6H-quinazolin-5-one O-3-(piperidin-4-yl)propyl oxime 
• 680570-15-4 1-{3-[1-(2-methoxy-ethyl)-piperidin-4-yl]-propyl}-1H-indole-2-carboxylic acid [2-(1-cyano-3-methyl-butylcarbamoyl)-cyclohexyl]-amide 

Relevant articles and documents

ADENINE DERIVATIVES WHICH ARE USEFUL IN THE TREATMENT OF ALLERGIC DISEASES OR OTHER INFLAMMATORY CONDITIONS

Compounds of formula (I).

NOVEL COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASES RELATED TO ACTIVATED LYMPHOCYTES

The present invention relates to inhibiting proliferation and inducing apoptosis in activated lymphocytes, including T cells and B cells. The invention also provides compositions and methods for inhibiting proliferation and inducing apoptosis in activated lymphocytes, as well methods for treating diseases associated with activated lymphocytes by administering 5-HT receptor antagonists.

PHARMACEUTICAL COMPOSITION AND METHOD USING ANTIFUNGAL AGENT IN COMBINATION

A pharmaceutical composition containing one or more antifungal agents selected from an arylamidine derivative represented by the general formula: (wherein R1 represents an amidino group that may be substituted with a hydroxyl group that may be